Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) (ITUB) vs Eli Lilly And Co (LLY) Price & Performance

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)Trade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) vs Eli Lilly And Co — how do they compare? Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) trades at $9.85 (market cap $113.15B), while Eli Lilly And Co trades at $1,167.12 (market cap $1.06T). The key difference: Eli Lilly And Co is far larger — about 9.4× Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)'s market cap, and Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) pays the higher dividend (1.76%). Which is the better fit depends on your goals — on Pluang, investors hold Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) for 0 Days and Eli Lilly And Co for 93 Days on average.

ITUBLLY
Market Cap
$113.15B$1.06T
Volume
41,687,3202,297,239
Sector
FinancialsHealth
52-Week High
$10.15$1.28K
52-Week Low
$6.76$799.57
Typical Hold Time
0 Days93 Days
Enterprise Value
$1.32T$1.11T
Dividend Yield
1.76%0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,169.93, up 1.07% on the day, with a bullish technical signal and strong fundamental momentum. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 exceeding the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights promising pipeline updates in weight-loss and diabetes drugs, reinforcing growth prospects.

Outlook remains favorable given dominant market position and innovation pipeline, though high valuation multiples pose a risk. Analyst consensus is strongly bullish with a $1,340 price target. Key risks include competitive pressures and execution challenges in scaling production to meet demand for blockbuster therapies.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ITUB
100% Buy0% Sell
Avg holding period · 0 Days
LLY
69% Buy31% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)

Itaú Unibanco is a Brazilian financial services company providing banking, credit, insurance, and investment products. It serves individual, business, and corporate clients.

Read more on ITUB →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →